激发性氨基酸作为治疗剂:通过解决激发性毒性来逆转神经退行性轨迹
Yogita Dhurandhar1, Shubham Tomar2, Kamta P Namdeo1
1Department of Pharmacy, Guru Ghasidas Vishwavidyalaya (A Central University), Bilaspur Chhattisgarh, 495009, India.
概括
D-氨基酸在治疗神经退行性疾病方面表现有前途,通过保护神经元免受刺激毒性的作用. 需要进一步的研究来探索它们的治疗潜力和输送方法,以改善患者的治疗结果.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
背景情况:
- 神经退行性疾病由于复杂的原因和无效的常规治疗方法,对全球健康构成挑战.
- 激发性氨基酸,包括D-氨基酸,因其在神经元功能和病理学中的潜在作用而受到关注.
- 通过N-甲基-D-酸盐受体 (NMDARs) 驱动过量的流引起的兴奋毒性是阿尔茨海默氏症等疾病的关键因素.
研究的目的:
- 审查D-氨基酸在神经保护中的新兴作用.
- 探索D-氨基酸作为神经退行性疾病的新疗法战略的潜力.
主要方法:
- 关于D-氨基酸研究近期进展的文献综述.
- 对减轻兴奋毒性和NMDAR过度活化的D-氨基酸机制的分析.
主要成果:
- D-氨基酸提供了替代的神经元信号通路.
- 它们表现出神经保护作用,防止刺激性损伤.
- 有潜力逆转神经退行性疾病的进展.
结论:
- D-氨基酸代表了神经退行性疾病的有希望的治疗途径.
- 进一步的研究对于了解它们的机制,进行临床试验和开发输送系统至关重要.
相关概念视频
Excitatory and Inhibitory Effects of Neurotransmitters
9.8K
When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of...
9.8K
Antiepileptic Drugs: Glutamate Antagonists
284
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
284
Alzheimer's Disease: Treatment
165
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
165
Drugs Affecting Neurotransmitter Synthesis
1.3K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.3K
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.1K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.1K
Neurochemical Transmission: Sites of Drug Action
2.1K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
2.1K


